Trials / Completed
CompletedNCT01831531
Study of S-1 in Combination With Radiotherapy in Esophageal Cancer
Phase II Study of S-1 in Combination With Radiotherapy in Esophageal Squamous Cell Carcinoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial aims to study the safety, the local control, and the overall survival of S-1 combined with radiotherapy for patients with esophageal squamous cell carcinoma. 105 patients will be recruited into this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-1 | S-1 40 mg (BSA ≤ 1.6 m2) or 50 mg (BSA \>1.6 m2) p.o bid d1-28 |
| RADIATION | Radiation therapy | A total dose of 61.2 Gy will be delivered in 34 fractions at 1.8 Gy/fraction, 5 fractions per week in 6.8 weeks. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2013-04-15
- Last updated
- 2019-02-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01831531. Inclusion in this directory is not an endorsement.